Your session is about to expire
← Back to Search
Recovery Processes for PTSD and Alcohol Use After Sexual Assault
N/A
Recruiting
Led By Michele Bedard-Gilligan, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Between the age of 18 and 65.
Identifies as female.
Must not have
Current diagnosis of bipolar disorder, depression with psychotic features, or depression severe enough to require immediate psychiatric treatment (i.e., serious suicide risk with intent and plan).
Unwilling or unable to discontinue current trauma-focused psychotherapy or current substance use psychotherapy.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up past month
Awards & highlights
No Placebo-Only Group
Summary
This trial will focus on understanding how to better treat people who have recently experienced sexual assault, in order to mitigate any long-term effects.
Who is the study for?
This trial is for women aged 18-65 who have experienced a sexual assault within the last year and are dealing with heavy alcohol use and PTSD. Participants must have internet access, a webcam, and a certain level of PTSD severity. Those on high doses of benzodiazepines or with severe mental health conditions like schizophrenia or bipolar disorder cannot join.
What is being tested?
The study tests how supportive telehealth, alcohol skills training, and imaginal exposure can help recovery from PTSD and reduce alcohol use after sexual assault. It aims to understand early treatment decisions that affect both fear and reward systems related to these conditions.
What are the potential side effects?
While specific side effects are not listed for this psychological intervention trial, participants may experience discomfort discussing traumatic events or changes in their drinking habits during the course of therapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 65 years old.
Select...
I identify as female.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently diagnosed with severe depression or bipolar disorder.
Select...
I cannot or will not stop my current therapy for trauma or substance use.
Select...
My mental health medication dose has been stable for the last 3 months.
Select...
I am taking a high dose of benzodiazepines.
Select...
I have been diagnosed with schizophrenia, delusional disorder, or another serious mental health condition.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ past month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~past month
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Alcohol Use Interview
Alcohol Use Self-Report
Posttraumatic Stress Disorder Severity (PTSD) Interview
+1 moreSecondary study objectives
Alcohol Consequences
Alcohol Cravings
Depression Interview
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
5Treatment groups
Experimental Treatment
Active Control
Group I: Imaginal Exposure First, then Alcohol SkillsExperimental Treatment2 Interventions
Imaginal exposure to the sexual assault memory targeting PTSD symptoms after sexual assault. After imaginal exposure, alcohol skills targeting alcohol misuse after sexual assault.
Group II: Imaginal Exposure First, no additional treatmentExperimental Treatment1 Intervention
Imaginal exposure to the sexual assault memory targeting PTSD symptoms after sexual assault. No additional treatment.
Group III: Alcohol Skills First, then Imaginal ExposureExperimental Treatment2 Interventions
Alcohol skills targeting alcohol misuse after sexual assault. After alcohol skills training, imaginal exposure to the sexual assault memory targeting PTSD symptoms after sexual assault.
Group IV: Alcohol Skills First, no additional treatmentExperimental Treatment1 Intervention
Alcohol skills targeting alcohol misuse after sexual assault only. No additional treatment.
Group V: Supportive Counseling/TelehealthActive Control1 Intervention
Internet-based intervention focusing on providing support.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Imaginal Exposure
2017
N/A
~40
Find a Location
Who is running the clinical trial?
University of WashingtonLead Sponsor
1,831 Previous Clinical Trials
1,907,389 Total Patients Enrolled
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
839 Previous Clinical Trials
1,083,468 Total Patients Enrolled
Michele Bedard-Gilligan, PhDPrincipal Investigator - University of Washington
University of Washington
2 Previous Clinical Trials
396 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 18 and 65 years old.I am currently diagnosed with severe depression or bipolar disorder.You are currently in a relationship with the person who committed the most recent assault against you.You do not remember the traumatic event clearly.You have consumed a large amount of alcohol (4 or more drinks on one occasion) at least twice in the past month.I identify as female.You have experienced sexual assault within the past year.I cannot or will not stop my current therapy for trauma or substance use.My mental health medication dose has been stable for the last 3 months.I am taking a high dose of benzodiazepines.I have been diagnosed with schizophrenia, delusional disorder, or another serious mental health condition.
Research Study Groups:
This trial has the following groups:- Group 1: Imaginal Exposure First, then Alcohol Skills
- Group 2: Alcohol Skills First, then Imaginal Exposure
- Group 3: Supportive Counseling/Telehealth
- Group 4: Alcohol Skills First, no additional treatment
- Group 5: Imaginal Exposure First, no additional treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.